Key result
Atrial-based Managed Ventricular Pacing (MVP) resulted in uncommon ECG and hemodynamic consequences in a patient with marked atrioventricular conduction delay.
Case Report (n=1)
This case report highlights uncommon ECG and hemodynamic consequences of atrial-based Managed Ventricular Pacing in a patient with marked AV conduction delay.
Answers are grounded in this paper and cite their sources.
May signal rare hemodynamic instability with MVP in marked AV delay; hypothesis-generating for pacing strategy selection in conduction disease.
AAIR7DDDR pacing (atrial-based Managed Ventricular Pacing [MVP]) is a novel pacing mode that facilitates intrinsic conduction whenever possible to mitigate the deleterious effects of prolonged duration right ventricular (RV) electric stimulation on left ventricular contractility.The following case illustrates uncommon ECG and hemodynamic consequences of this algorithm in a patient with marked atrioventricular (AV) conduction delay.
No takes yet. Share an insight, caveat, or question.
Andrew M. Rosenblum (2010) conducted a case report in Marked atrioventricular (AV) conduction delay (n=1). AAIR7DDDR pacing (atrial-based Managed Ventricular Pacing [MVP]) was evaluated on ECG and hemodynamic consequences. Atrial-based Managed Ventricular Pacing (MVP) resulted in uncommon ECG and hemodynamic consequences in a patient with marked atrioventricular conduction delay.
Synapse has enriched 10 related papers. Consider them for comparative context: